Skip to content

PP&E (Net) at other companies

Merck & Co. logo
Merck & Co.MRK
$25.43B+2.6%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$18.43M+70.9%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$81.51M-16.7%
HRO
HarrowHROW
$3.13M-12.3%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$5.54M-21.2%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$239M-8.4%

Segments

By geography

See full
US$8.18M
CN$0
GB$0

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's PP&E (net)?
EyePoint, Inc. (EYPT) reported PP&E (net) of $9.48M in Q1 2026.
How has EyePoint, Inc. 's PP&E (net) changed year-over-year?
EyePoint, Inc. 's PP&E (net) increased by 17.9% year-over-year, from $8.04M to $9.48M.
What is the long-term trend for EyePoint, Inc. 's PP&E (net)?
Over 5 years (2020 to 2025), EyePoint, Inc. 's PP&E (net) has grown at a 70.3% compound annual growth rate (CAGR), from $630K to $9.02M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.